Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients

SummaryWe have analysed DNA extracted from the serum and peritoneal fluid of 20 ovarian cancer patients for the presence of tumour-specific genetic alterations. The 20 patients included six with stage Ia disease. Using six polymorphic microsatellite loci we were able to detect novel alleles or loss of heterozygosity in 17/20 serum samples and 12/19 peritoneal fluid samples. Tumour-specific abnormalities were detected in the serum of all but one of the stage Ia cases. Half of the occurrences of loss of heterozygosity identified in primary tumour material were detectable in the serum samples. Novel alleles indicative of microsatellite instability were found in 3/6 patients with stage Ia disease but in only 1/14 of patients with more advanced disease. One of the eight patients in the control group displayed abnormalities in her serum DNA. The ease with which tumour-specific alterations were detected in serum and peritoneal samples from ovarian cancer patients, using a panel of only six polymorphic microsatellite markers on four chromosomes, suggests that molecular detection methods could prove useful in the staging, monitoring and screening of this disease.

[1]  L. Aaltonen,et al.  Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. , 1993, Cancer research.

[2]  L. Hartmann,et al.  Human epithelial ovarian cancer allelotype. , 1993, Cancer research.

[3]  J. Zenklusen,et al.  Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. , 1995, Oncogene.

[4]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[5]  Cécile Fizames,et al.  The 1993–94 Généthon human genetic linkage map , 1994, Nature Genetics.

[6]  Y S Erozan,et al.  Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis , 1996, Science.

[7]  C. Caldas.  Molecular staging of cancer: is it time? , 1997, The Lancet.

[8]  W. Droegemueller.  Screening for ovarian carcinoma: hopeful and wishful thinking. , 1994, American journal of obstetrics and gynecology.

[9]  I. Kirsch,et al.  Prognostic significance of DNA replication errors in young patients with colorectal cancer. , 1998, Annals of surgery.

[10]  R. Hruban,et al.  Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.

[11]  R. Bast,et al.  Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers , 1995, Cancer.

[12]  K. Kinzler,et al.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.

[13]  K. Buetow,et al.  Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. , 1995, Cancer research.

[14]  Bratin Saha,et al.  Allelic loss on chromosome 17 in human ovarian cancer , 1993, International journal of cancer.

[15]  R. Bast,et al.  Elevation of multiple serum markers in patients with stage I ovarian cancer. , 1993, Journal of the National Cancer Institute.

[16]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[17]  M. Pieretti,et al.  The molecular basis of ovarian cancer , 1995, Cancer.

[18]  M. Kiechle,et al.  Microsatellite instability in ovarian neoplasms. , 1995, British Journal of Cancer.

[19]  A. Sood,et al.  Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. , 1996, Oncogene.

[20]  D. Grignon,et al.  Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. , 1995, Cancer research.

[21]  K. Pittman,et al.  Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction , 1991, The Lancet.

[22]  M. Leppert,et al.  A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. , 1993, American journal of human genetics.

[23]  W. Bodmer,et al.  Selection for β2-microglobulin mutation in mismatch repair-defective colorectal carcinomas , 1996, Current Biology.

[24]  R. Osborne,et al.  Polymerase chain reaction allelotyping of human ovarian cancer. , 1994, British Journal of Cancer.

[25]  M. Inoue,et al.  Microsatellite instability and alterations in the HMSH2 gene in human ovarian cancer , 1995, International journal of cancer.

[26]  J. Jen,et al.  Molecular detection of genetic alterations in the serum of colorectal cancer patients. , 1998, Cancer research.

[27]  L. Cawkwell,et al.  Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. , 1994, British Journal of Cancer.